Cartilage T2 Mapping

QUIBIM

QUIBIM has developed a non-invasive post-processing application to obtain cartilage the T2 mapping of the femoral cartilage using AI to automatically segment the cartilage. T2 mapping helps depicting changes and abnormalities in the cartilage matrix.
Product specifications Information source: Vendor
Last updated: March 10, 2020
General
Product name Cartilage T2 Mapping
Company QUIBIM
Subspeciality MSK
Modality MR
Disease targeted Osteoarthritis, Inflammatory disease, Cartilage quality, Degenerative disease, Sports-related diseases and conditions
Key-features Automatic cartilage segmentation, T2 Values
Suggested use Without interference of a radiologist: AI-only diagnosis
Data characteristics
Population Patients with degenerative or inflammatory diseases of the joints
Input MR 3D T2 Gradient Echo with high contrast between bone and cartilage T2 Multi-echo
Input format
Output One-page structured report: 3D reconstruction of the femoral cartilage, T2 cartilage histogram, T2 values per parcel
Output format DICOM Secondary Capture / PDF
Technology
Integration Integration in standard reading environment (PACS), Integration via AI marketplace or distribution platform, Stand-alone third party application, Stand-alone webbased
Deployment Locally on dedicated hardware, Locally virtualized (virtual machine, docker), Cloud-based, Hybrid solution
Trigger for analysis Automatically, right after the image acquisition
Processing time 1 - 10 minutes
Certification
CE Certified, Class IIa
FDA No or not yet
Market presence
On market since 01-2019
Distribution channels
Countries present (clinical, non-research use) 2
Paying clinical customers (institutes) 5+
Research/test users (institutes) <5
Pricing
Pricing model License
Based on Number of installations, Number of analyses
Evidence
Peer reviewed papers on performance
Non-peer reviewed papers on performance
Other relevant papers